HK46996A - Use of naftopidil for the treatment of dysuria caused by benign prostate hypertrophy - Google Patents

Use of naftopidil for the treatment of dysuria caused by benign prostate hypertrophy

Info

Publication number
HK46996A
HK46996A HK46996A HK46996A HK46996A HK 46996 A HK46996 A HK 46996A HK 46996 A HK46996 A HK 46996A HK 46996 A HK46996 A HK 46996A HK 46996 A HK46996 A HK 46996A
Authority
HK
Hong Kong
Prior art keywords
treatment
naftopidil
prostate hypertrophy
benign prostate
dysuria caused
Prior art date
Application number
HK46996A
Other languages
English (en)
Inventor
Gisbert Dr Med Vet Sponer
Ulrich Reicke
Michael D Nelboeck-Hochstetter
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK46996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HK46996A publication Critical patent/HK46996A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HK46996A 1989-06-07 1996-03-14 Use of naftopidil for the treatment of dysuria caused by benign prostate hypertrophy HK46996A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie

Publications (1)

Publication Number Publication Date
HK46996A true HK46996A (en) 1996-03-22

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
HK46996A HK46996A (en) 1989-06-07 1996-03-14 Use of naftopidil for the treatment of dysuria caused by benign prostate hypertrophy

Country Status (19)

Country Link
US (1) US5026706A (fr)
EP (1) EP0401653B1 (fr)
JP (1) JPH062673B2 (fr)
KR (1) KR0131452B1 (fr)
AT (1) ATE84416T1 (fr)
AU (1) AU625766B2 (fr)
CA (1) CA2017619C (fr)
DD (1) DD294864A5 (fr)
DE (2) DE3918543A1 (fr)
DK (1) DK0401653T3 (fr)
ES (1) ES2054147T3 (fr)
GR (1) GR3007328T3 (fr)
HK (1) HK46996A (fr)
HU (1) HU206976B (fr)
IE (1) IE62937B1 (fr)
IL (1) IL94601A (fr)
PH (1) PH26690A (fr)
PT (1) PT94268B (fr)
ZA (1) ZA904338B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
IL94601A (en) 1994-06-24
DK0401653T3 (da) 1993-03-29
AU625766B2 (en) 1992-07-16
HU903515D0 (en) 1990-10-28
IE902014L (en) 1990-12-07
IE62937B1 (en) 1995-03-08
DE3918543C2 (fr) 1991-06-06
DD294864A5 (de) 1991-10-17
GR3007328T3 (fr) 1993-07-30
KR910000152A (ko) 1991-01-29
PT94268A (pt) 1991-02-08
EP0401653B1 (fr) 1993-01-13
AU5628290A (en) 1990-12-13
ES2054147T3 (es) 1994-08-01
JPH0324014A (ja) 1991-02-01
US5026706A (en) 1991-06-25
ATE84416T1 (de) 1993-01-15
EP0401653A2 (fr) 1990-12-12
JPH062673B2 (ja) 1994-01-12
KR0131452B1 (ko) 1998-04-17
PH26690A (en) 1992-09-15
HUT54494A (en) 1991-03-28
CA2017619A1 (fr) 1990-12-07
EP0401653A3 (fr) 1991-07-17
CA2017619C (fr) 1995-06-20
PT94268B (pt) 1997-01-31
DE59000748D1 (de) 1993-02-25
IL94601A0 (en) 1991-04-15
DE3918543A1 (de) 1990-12-13
HU206976B (en) 1993-03-01
ZA904338B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
FR2442839B1 (fr)
EP0350846A3 (en) Condensed heterocyclic compounds and their use in therapy
ZA919629B (en) Novel 4-arylpiperazines and 4-arylpiperidines
DK262585A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
ATE130589T1 (de) Verwendung von wässrigen kationischen kunststoffdispersionen zum imprägnieren und grundieren von saugfähigen substraten.
AU8196282A (en) Bispidine derivatives with antiarrhythmic activity
FR2440946B2 (fr)
HK46996A (en) Use of naftopidil for the treatment of dysuria caused by benign prostate hypertrophy
NZ195450A (en) Regulating plant growth with 1-phenoxy-3 3-dimethyl-2-(pyrimidin-5-yl) butan-2-ols
DK504389D0 (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
DK437886D0 (da) Makrocycliske antibiotika samt deres fremstilling og anvendelse
ES2018208B3 (es) Derivados de hidroxipirazol, procedimiento para su obtencion y su aplicacion contra microorganismos.
FR2517679B1 (fr)
AU571414B2 (en) Oxaazaphosphorine derivatives
DE69307769D1 (de) Neue Verwendung von (S) Amino-2-dichloro-3,4-benzyl)-2-propanol-1 Enantiomere Derivate

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090530